A profusion of promising treatment options exists for breast cancers. Pharmacists are crucial to helping patients and clinical teams choose among these options, according to two clinicians with experience in this multidisciplinary approach.
For metastatic breast cancer, past regimens were limited to aromatase inhibitors or tamoxifen, in addition to standard chemotherapy, noted Heather Moore, PharmD, a clinical pharmacist practitioner at the Duke Cancer Center Breast Clinic, in